No menu items!
spot_img

MINILUXE COMPLETES SHARES FOR DEBT SETTLEMENT

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, Sept. 26,...

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by Fraud — Contact BFA Law about its Investigation

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty...

Top Stories

MINILUXE COMPLETES SHARES FOR DEBT SETTLEMENT

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) (“MiniLuxe” or the “Company”) announces that, further to its press release dated September 5,...

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by...

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by...

Most Popular

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by...

TryHard Holdings Limited Celebrates Nasdaq Listing with Closing Bell Ceremony, Marking...

Love Buying British Introduces Comprehensive Directory Connecting Consumers with Authentic British-Made...

Beauty and Personal Care Products Market Report by Type, Product, Pricing,...

MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase...

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding...

New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across TexasTORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free therapies for ablating...

MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to...

ROCKVILLE, Md., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced a restructuring of its operations to better align resources with its strategic priorities....
spot_img

Category

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate...

Baijiayun and Xinlantian Reached Strategic Cooperation to Use AI Technology to...